Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulence.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2015-01-22

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm500955sPMID 25470204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting virulence not viability in the search for future antibacterials.

  2015cited by this paper
• Comparative Sequence, Structure and Redox Analyses of Klebsiella pneumoniae DsbA Show That Anti-Virulence Target DsbA Enzymes Fall into Distinct Classes

  2013cited by this paper
• The 1.2 Å resolution crystal structure of TcpG, the Vibrio cholerae DsbA disulfide-forming protein required for pilus and cholera-toxin production.

  2012cited by this paper
• Peptides and Proteins as a Continuing Exciting Source of Inspiration for Peptidomimetics

  2011cited by this paper
• Overview of the CCP4 suite and current developments

  2011cited by this paper
• The expanding scope of antimicrobial peptide structures and their modes of action.

  2011cited by this paper
• Protein thermal shifts to identify low molecular weight fragments.

  2011cited by this paper
• Structure and Function of DsbA, a Key Bacterial Oxidative Folding Catalyst

  2011cited by this paper
• Inhibitors of cathepsin C (dipeptidyl peptidase I)

  2010cited by this paper
• Features and development of Coot

  2010cited by this paper
• The pleuromutilin antibiotics: a new class for human use.

  2010cited by this paper
• Anti-virulence strategies to combat bacteria-mediated disease

  2010cited by this paper
• Dynamic nature of disulphide bond formation catalysts revealed by crystal structures of DsbB

  2009cited by this paper
• Estimation of Disulfide Bonds Using Ellman’s Reagent

  2009cited by this paper
• Detecting folding intermediates of a protein as it passes through the bacterial translocation channel.

  2009cited by this paper
• Antimicrobial peptide mimics for improved therapeutic properties.

  2009cited by this paper
• Characterization of Two Homologous Disulfide Bond Systems Involved in Virulence Factor Biogenesis in Uropathogenic Escherichia coli CFT073

  2009cited by this paper
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

  2009cited by this paper
• DSB proteins and bacterial pathogenicity

  2009cited by this paper
• New approaches in peptide antibiotics.

  2009cited by this paper
• Preparation and structure of the charge‐transfer intermediate of the transmembrane redox catalyst DsbB

  2008cited by this paper
• Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation

  2008cited by this paper
• DsbA directs efficient expression of outer membrane secretin EscC of the enteropathogenic Escherichia coli type III secretion apparatus.

  2008cited by this paper
• Targeting virulence: a new paradigm for antimicrobial therapy

  2007cited by this paper
• Phaser crystallographic software

  2007cited by this paper
• Crystal structure of the DsbB-DsbA complex reveals a mechanism of disulfide bond generation.

  2006cited by this paper
• Protease inhibitors in the clinic.

  2005cited by this paper
• Protein production by auto-induction in high density shaking cultures.

  2005cited by this paper
• Ligand efficiency indices as guideposts for drug discovery.

  2005cited by this paper
• Characteristic physical properties and structural fragments of marketed oral drugs.

  2004cited by this paper
• Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines.

  2002cited by this paper
• Four cysteines of the membrane protein DsbB act in concert to oxidize its substrate DsbA

  2002cited by this paper
• Irreversible inhibitors of serine, cysteine, and threonine proteases.

  2002cited by this paper
• Development of daptomycin for gram-positive infections.

  2000cited by this paper
• Reconstitution of a Protein Disulfide Catalytic System*

  1998cited by this paper
• Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolid.

  1997cited by this paper
• Efficient production of heat-labile enterotoxin mutant proteins by overexpression of dsbA in a degP-deficient Escherichia coli strain

  1997cited by this paper
• Preferential binding of an unfolded protein to DsbA.

  1996cited by this paper
• The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal.

  1996cited by this paper
• PapD chaperone function in pilus biogenesis depends on oxidant and chaperone-like activities of DsbA.

  1994cited by this paper
• A pathway for disulfide bond formation in vivo.

  1993cited by this paper
• Crystal structure of the DsbA protein required for disulphide bond formation in vivo

  1993cited by this paper
• Mutants in disulfide bond formation that disrupt flagellar assembly in Escherichia coli.

  1993cited by this paper
• Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites.

  1992cited by this paper
• Identification of a protein required for disulfide bond formation in vivo.

  1991cited by this paper
• A putative glutathione-binding site in T4 glutaredoxin investigated by site-directed mutagenesis.

  1991cited by this paper
• Bioactive conformation of linear peptides in solution: An elusive goal?

  1989cited by this paper
• Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.

  1987cited by this paper
• Electronic Reprint Biological Crystallography Phenix : a Comprehensive Python-based System for Macromolecular Structure Solution

  year unknowncited by this paper

• The disulfide bond formation (DSB) system: so much more than a housekeeper.

  2025cites this paper
• Identification of an Allene Warhead That Selectively Targets a Histidine Residue in the Escherichia coli Oxidoreductase Enzyme DsbA.

  2025cites this paper
• Phase‐Separated Nano‐Antibiotics Enhanced Survival in Multidrug‐Resistant Escherichia coli Sepsis by Precise Periplasmic EcDsbA Targeting

  2024cites this paper
• Cell envelope structural and functional contributions to antibiotic resistance in Burkholderia cenocepacia

  2024influential citation
• New avenues of combating antibiotic resistance by targeting cryptic pockets.

  2024cites this paper
• Making a chink in their armor: Current and next-generation antimicrobial strategies against the bacterial cell envelope.

  2023cites this paper
• Fragment screening libraries for the identification of protein hot spots and their minimal binding pharmacophores.

  2023cites this paper
• Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis

  2023cites this paper
• Using display technologies to identify macrocyclic peptide antibiotics.

  2023cites this paper
• The suppressor of copper sensitivity protein C from Caulobacter crescentus is a trimeric disulfide isomerase that binds copper(I) with subpicomolar affinity

  2022cites this paper
• Direct Observation of the Mechanical Role of Bacterial Chaperones in Protein Folding.

  2022cites this paper
• Fluoromethylketone‐Fragment Conjugates Designed as Covalent Modifiers of EcDsbA are Atypical Substrates

  2022influential citation
• Structural bioinformatic analysis of DsbA proteins and their pathogenicity associated substrates

  2021cites this paper
• Deciphering the role of sulfonamides and molecular basis of thioredoxin domain dynamics through comparative simulations

  2021cites this paper
• Identification and characterization of two drug-like fragments that bind to the same cryptic binding pocket of Burkholderia pseudomallei DsbA

  2021cites this paper
• Direct Observation of the Mechanical Role of Bacterial Chaperones in Protein Folding

  2021cites this paper
• Generowanie MostkÓW Disiarczkowych W BiaŁKach – RÓŻNorodnoŚĆ Strukturalna I Funkcjonalna BiaŁEk Dsba

  2021cites this paper
• Elaboration of a benzofuran scaffold and evaluation of binding affinity and inhibition of Escherichia coli DsbA: A fragment-based drug design approach to novel antivirulence compounds.

  2021cites this paper
• Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding

  2021cites this paper
• Selective Binding of Small Molecules to Vibrio cholerae DsbA Offers a Starting Point for the Design of Novel Antibacterials

  2021cites this paper
• Thiol and Disulfide Containing Vancomycin Derivatives Against Bacterial Resistance and Biofilm Formation

  2021cites this paper
• Interplay between DsbA1, DsbA2 and C8J_1298 Periplasmic Oxidoreductases of Campylobacter jejuni and Their Impact on Bacterial Physiology and Pathogenesis

  2021cites this paper
• The Mechanical Roles of Chaperons

  2020cites this paper
• The Mechanical Roles of Chaperones

  2020cites this paper
• Periplasmic targets for the development of effective antimicrobials against gram-negative bacteria.

  2020cites this paper
• Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era

  2019cites this paper
• The Fragment-Based Development of a Benzofuran Hit as a New Class of Escherichia coli DsbA Inhibitors

  2019cites this paper
• Engineering of the Dsb (disulfide bond) proteins – contribution towards understanding their mechanism of action and their applications in biotechnology and medicine

  2019cites this paper
• Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB

  2018cites this paper
• Disulfide bond formation in prokaryotes

  2018cites this paper
• Enzyme targets for drug design of new anti-virulence therapeutics.

  2018cites this paper
• DsbA is a redox-switchable mechanical chaperone

  2018cites this paper
• Bacterial thiol oxidoreductases — from basic research to new antibacterial strategies

  2017cites this paper
• From Biology to Biotechnology: Disulfide Bond Formation in Escherichia coli

  2017cites this paper
• Inhibition of Diverse DsbA Enzymes in Multi-DsbA Encoding Pathogens

  2017cites this paper
• A shape-shifting redox foldase contributes to Proteus mirabilis copper resistance

  2017cites this paper
• Control of Shigella sonnei and adhesive invasive Escherichia coli infections with a natural product which inhibits the bacterial oxidoreductase DsbA

  2017cites this paper
• Targeting Bacterial Dsb Proteins for the Development of Anti-Virulence Agents

  2016cites this paper
• Structural and Biochemical Characterization of Chlamydia trachomatis DsbA Reveals a Cysteine-Rich and Weakly Oxidising Oxidoreductase

  2016cites this paper
• Altered Escherichia coli membrane protein assembly machinery allows proper membrane assembly of eukaryotic protein vitamin K epoxide reductase

  2015cites this paper
• Diversity of the Epsilonproteobacteria Dsb (disulfide bond) systems

  2015cites this paper
• Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbA

  2015cites this paper
• Disulfide-Bond-Forming Pathways in Gram-Positive Bacteria

  2015cites this paper